Menarini: Modern Masters

 We’ve come a long way since replacement insulin first became available. 

Today, astonishing progress has being made. Modern treatment advances include Invokana, protecting patients with type 2 diabetes from major CV events and kidney failure. However, the SGLT2 market is competitive. A market where only a team with a desire to hone its craft, its acumen and passion to make a positive impact can leave a legacy. 

With a strong Italian heritage, Menarini are home to the Invokana team. We developed an internal communications campaign and training programme with a nod to the highly influential Masters from the Renaissance period. The Invokana have inspired the Modern Masters programme for pioneering excellence in diabetic patient care. The members of the team are captured and showcased in personalised painting which all have a subtle link to the modern day.